Skip to content


NHT has assembled a highly qualified and experienced team to develop the first drug/device therapy product utilizing the DryNeb™ nebulizer. The company’s advisory board of comprises experienced pulmonary drug delivery experts who are knowledgeable in patient care, drug repurposing, drug formulation, device engineering, efficacy, and clinical trials – all important to the platform technology and drug/device product development.

The Executive Team

Board of Directors

    • Paul Atkins, PhD – Executive Chairman
    • Yun Li, PhD – CEO
    • Calvin Goforth, PhD – Director

Strategic Advisory Board